Verified ProfileEN

Jiangsu Weigao Biotechnology Co., Ltd.

Order verification — $199

Manufacturing · Chemical Pharmaceutical Raw Material Manufacturing

Verification dossier

Jiangsu Weigao Biotechnology Co., Ltd. is a Chinese company based in Huai'an, Jiangsu. The company operates in the chemical pharmaceutical raw material manufacturing sector, within the broader manufacturing industry. Established 2017, the company has been operating for 9 years.

Sinolinks tracks Jiangsu Weigao Biotechnology Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Technical development, technical consulting, and technical services in the field of biology; production and sales of protein feed, heparin sodium, and lard; processing and sales of pig small intestines and casings; acquisition of pig small intestines and lungs; sales of mechanical equipment, chemical products and raw materials (excluding hazardous chemicals), and electronic products; import and export business of self-produced products and technologies, and import of necessary machinery, parts, raw materials and technologies, excluding goods and technologies restricted or prohibited by the state.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review